Multiple sclerosis progression: time for a new mechanism-driven framework
Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—
relapsing-remitting, secondary progressive, and primary progressive—for patient care …
relapsing-remitting, secondary progressive, and primary progressive—for patient care …
Recommendations for cognitive screening and management in multiple sclerosis care
Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS),
recommend optimal screening, monitoring, and treatment strategies, and address barriers to …
recommend optimal screening, monitoring, and treatment strategies, and address barriers to …
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
Background: There is limited and inconsistent information on the clinical determinants of
cognitive impairment (CI) in multiple sclerosis (MS). Objective: The aim of this study was to …
cognitive impairment (CI) in multiple sclerosis (MS). Objective: The aim of this study was to …
Multiple sclerosis and cognition: synaptic failure and network dysfunction
Cognitive impairment is increasingly recognized to be a core feature of multiple sclerosis
(MS), with important implications for the everyday life of individuals with MS and for disease …
(MS), with important implications for the everyday life of individuals with MS and for disease …
Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms—a narrative review
L Lakin, BE Davis, CC Binns, KM Currie… - Neurology and therapy, 2021 - Springer
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …
system, leading to neurodegeneration and manifesting as a variety of symptoms. These can …
[HTML][HTML] Cognitive impairment in multiple sclerosis: an update on assessment and management
E Portaccio, MP Amato - NeuroSci, 2022 - mdpi.com
Cognitive impairment (CI) is a core feature of multiple sclerosis (MS) and affects up to 65%
of patients in every phase of the disease, having a deep impact on all aspects of patients' …
of patients in every phase of the disease, having a deep impact on all aspects of patients' …
“No evident disease activity”: the use of combined assessments in the management of patients with multiple sclerosis
Using combined endpoints to define no evident disease activity (NEDA) is becoming
increasingly common when setting targets for treatment outcomes in multiple sclerosis (MS) …
increasingly common when setting targets for treatment outcomes in multiple sclerosis (MS) …
The prevalence of cognitive impairment in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis
It is increasingly recognized that cognitive symptoms are a common sequelae of relapsing-
remitting multiple sclerosis and are associated with adverse functional consequences …
remitting multiple sclerosis and are associated with adverse functional consequences …
Cognitive dysfunction in the early stages of multiple sclerosis—how much and how important?
M Oset, M Stasiolek, M Matysiak - Current neurology and neuroscience …, 2020 - Springer
Abstract Purpose of Review Multiple sclerosis (MS) is a demyelinating disease of the central
nervous system that mainly affects young adults and that is one of the leading causes of …
nervous system that mainly affects young adults and that is one of the leading causes of …
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
Background: Multiple sclerosis (MS) is a chronic immune-mediated disease of the central
nervous system (CNS). Although cognitive impairment (CI) affects a large proportion of MS …
nervous system (CNS). Although cognitive impairment (CI) affects a large proportion of MS …